JACOBS LEVY EQUITY MANAGEMENT, INC - HARMONY BIOSCIENCES HLDGS IN ownership

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 241 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2022. The put-call ratio across all filers is 1.21 and the average weighting 0.7%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of HARMONY BIOSCIENCES HLDGS IN
ValueSharesWeighting
Q3 2023$7,697,280
-23.5%
234,888
-17.9%
0.05%
-20.7%
Q2 2023$10,065,185
-18.1%
286,024
-24.0%
0.06%
-22.7%
Q1 2023$12,289,003
-41.2%
376,386
-0.7%
0.08%
-46.8%
Q4 2022$20,884,388
+12.0%
379,027
-10.0%
0.14%
-4.1%
Q3 2022$18,653,000421,1650.15%
Other shareholders
HARMONY BIOSCIENCES HLDGS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$367,614,94198.94%
Nan Fung Group Holdings Ltd 368,665$12,081,1529.78%
venBio Partners LLC 1,035,396$33,929,9279.62%
Vivo Capital, LLC 2,606,247$85,406,7149.36%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 314,500$10,306,1653.47%
AlphaCentric Advisors LLC 122,000$3,997,9402.27%
ASHFORD CAPITAL MANAGEMENT INC 434,148$14,227,0302.09%
Altium Capital Management LP 117,000$3,834,0902.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 595,490$19,514,2071.90%
TANG CAPITAL MANAGEMENT LLC 271,200$8,887,2241.25%
View complete list of HARMONY BIOSCIENCES HLDGS IN shareholders